Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ZB-131 by ZielBio for Metastatic Pancreatic Cancer: Likelihood of Approval
ZB-131 is under clinical development by ZielBio and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData, Phase...
ZB-131 by ZielBio for Metastatic Biliary Tract Cancer: Likelihood of Approval
ZB-131 is under clinical development by ZielBio and currently in Phase II for Metastatic Biliary Tract Cancer. According to GlobalData,...
ZB-131 by ZielBio for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
ZB-131 is under clinical development by ZielBio and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
ZB-131 by ZielBio for Extrahepatic Bile Duct Cancer: Likelihood of Approval
ZB-131 is under clinical development by ZielBio and currently in Phase II for Extrahepatic Bile Duct Cancer. According to GlobalData,...
ZB-131 by ZielBio for Ovarian Cancer: Likelihood of Approval
ZB-131 is under clinical development by ZielBio and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...